title: Does genetic susceptibility increase risk for neurocognitive decline among patients with acute lymphoblastic leukemia?
authors.affiliation: Albert Einstein College of Medicine, 1225 Morris Park Avenue, Van Etten Building, Room VE 6A03, Bronx, NY 10461, USA.|The Children's Hospital at Montefiore, 3415 Bainbridge Avenue, Bronx, NY 10467, USA.
authors.forename: Peter D
authors.initials: PD
authors.lastname: Cole
mesh_terms: D017850:Economics, Pharmaceutical; D020022:Genetic Predisposition to Disease; D006801:Humans; D008727:Methotrexate / Q000009:adverse effects* / Q000627:therapeutic use; D019965:Neurocognitive Disorders / Q000139:chemically induced / Q000235:genetics / Q000473:pathology; D018384:Oxidative Stress / Q000235:genetics; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000235:genetics; D012307:Risk Factors
chemical_list: D008727:Methotrexate
keywords: acute lymphoblastic leukemia; methotrexate; neurocognitive function; oxidative stress; pharmacogenomics